B.E. van den Borne
About
In The Last Decade
B.E. van den Borne
10 papers receiving 205 citations
Peers
Comparison fields: 5 of 50
- Oncology 103
- Pulmonary and Respiratory Medicine 99
- Epidemiology 37
- Molecular Biology 32
- Rheumatology 29
Countries citing papers authored by B.E. van den Borne
This map shows the geographic impact of B.E. van den Borne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.E. van den Borne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.E. van den Borne more than expected).
Fields of papers citing papers by B.E. van den Borne
This network shows the impact of papers produced by B.E. van den Borne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.E. van den Borne. The network helps show where B.E. van den Borne may publish in the future.
Co-authorship network of co-authors of B.E. van den Borne
This figure shows the co-authorship network connecting the top 25 collaborators of B.E. van den Borne. A scholar is included among the top collaborators of B.E. van den Borne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.E. van den Borne. B.E. van den Borne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 51 | |
| 3 | 64 | |
| 4 | 14 | |
| 5 | 31 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 8 | |
| 9 | 1 | |
| 10 | Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine. | 32 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.